<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Roche AB - bilder</title>
    <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/list</link>
    <description>Mynewsdesk nyhetsfeed direkt fr&#229;n k&#228;llan</description>
    <image>
      <title>Roche AB - bilder</title>
      <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/list</link>
      <url>http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png</url>
      <width>128</width>
      <height>23</height>
    </image>
    <language>sv</language>
    <ttl>15</ttl>
<item>
  <title>Zelboraf ( vemurafenib)</title>
  <pubDate>Thu, 24 Nov 2011 12:15:37 +0100</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/zelboraf-vemurafenib-103531" title="Zelboraf ( vemurafenib)"&gt;&lt;img alt="Zelboraf ( vemurafenib)" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/pills-zelboraf.jpg" title="Zelboraf ( vemurafenib)" /&gt;&lt;/a&gt;
    &lt;p&gt;Zelboraf ( vemurafenib) mot malignt melanom fungerar genom att den blockerar signalv&#228;garna i cancercellerna s&#229; att den okontrollerade celldelningen h&#228;mmas och d&#228;rigenom bromsar tum&#246;rtillv&#228;xten. Den okontrollerade celldelningen beror p&#229; en genmutation som ligger bakom h&#228;lften av alla fall av malignt melanom.

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/zelboraf-vemurafenib-103531?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/zelboraf-vemurafenib-103531?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Zelboraf f&#246;rpackning</title>
  <pubDate>Thu, 24 Nov 2011 12:12:54 +0100</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/zelboraf-foerpackning-103528" title="Zelboraf f&#246;rpackning"&gt;&lt;img alt="Zelboraf f&#246;rpackning" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/zelboraf.jpg" title="Zelboraf f&#246;rpackning" /&gt;&lt;/a&gt;
    &lt;p&gt;Zelboraf ( vemurafenib) mot malignt melanom fungerar genom att den blockerar signalv&#228;garna i cancercellerna s&#229; att den okontrollerade celldelningen h&#228;mmas och d&#228;rigenom bromsar tum&#246;rtillv&#228;xten. Den okontrollerade celldelningen beror p&#229; en genmutation som ligger bakom h&#228;lften av alla fall av malignt melanom.

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/zelboraf-foerpackning-103528?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/zelboraf-foerpackning-103528?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Inflammerad fingerled </title>
  <pubDate>Fri, 09 Sep 2011 18:16:47 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/inflammerad-fingerled-92122" title="Inflammerad fingerled "&gt;&lt;img alt="Inflammerad fingerled " src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/0050814-1.jpg" title="Inflammerad fingerled " /&gt;&lt;/a&gt;
    &lt;p&gt;Den h&#228;r fingerleden &#228;r inflammerad och r&#246;relseomf&#229;nget och styrkan i leden &#228;r ordentligt nersatt.&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/inflammerad-fingerled-92122?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/inflammerad-fingerled-92122?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Avastin</title>
  <pubDate>Wed, 07 Sep 2011 10:35:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/avastin-91513" title="Avastin"&gt;&lt;img alt="Avastin" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/5504.jpg" title="Avastin" /&gt;&lt;/a&gt;
    &lt;p&gt;Avastin (bevacizumab) &#228;r en antikropp som h&#228;mmar bildandet av nya blodk&#228;rl till cancertum&#246;rer, vilket leder till att tum&#246;ren krymper p&#229; grund av brist p&#229; syre och n&#228;ring. Avastin och den f&#246;rsta och hittills enda godk&#228;nda specifika VEGF-h&#228;mmaren. Avastin &#228;r godk&#228;nt inom EU f&#246;r behandling av spridd br&#246;stcancer, tarmcancer (tjock- och &#228;ndtarmscancer), lungcancer, samt njurcellscancer. &lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/avastin-91513?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/avastin-91513?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Herceptin</title>
  <pubDate>Wed, 07 Sep 2011 10:19:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/herceptin-91510" title="Herceptin"&gt;&lt;img alt="Herceptin" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/5067.jpg" title="Herceptin" /&gt;&lt;/a&gt;
    &lt;p&gt;Herceptin (trastuzumab) &#228;r en antikropp som anv&#228;nds vid behandling av HER2-positiv br&#246;stcancer. N&#228;r Herceptin binder till HER2 stoppas cellproliferationen, det vill s&#228;ga tillv&#228;xten, vilket leder till att cancercellerna d&#246;r. Herceptin stimulerar &#228;ven immunsystemet till att d&#246;da cancercellerna genom s&#229; kallad antikroppsberoende cellmedierad cytotoxicitet (ADCC).

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/herceptin-91510?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/herceptin-91510?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>&#196;ggstockar</title>
  <pubDate>Mon, 06 Jun 2011 16:07:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/aeggstockar-81021" title="&#196;ggstockar"&gt;&lt;img alt="&#196;ggstockar" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/location_of_ovaries_sv.jpg" title="&#196;ggstockar" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aeggstockar-81021?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aeggstockar-81021?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>&#196;ggstockscancer</title>
  <pubDate>Mon, 06 Jun 2011 16:03:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/aeggstockscancer-81020" title="&#196;ggstockscancer"&gt;&lt;img alt="&#196;ggstockscancer" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/ovarian_cancer_types_sv.jpg" title="&#196;ggstockscancer" /&gt;&lt;/a&gt;
    &lt;p&gt;&#196;ggstockscancer utvecklas med diffusa symptom. Sjukdomen delas in i stadier efter sv&#229;righetsgrad. Stadium I: Cancer enbart i &#228;ggstockarna. Stadium II: Cancer i ena eller b&#229;da &#228;ggstockarna med utbredning i b&#228;ckenet. Stadium III: Cancern har spridit sig till bukh&#229;lan. Den kan &#228;ven finnas i lymfk&#246;rtlar Stadium IV: Spridning. Det finns, s&#229; kallade, fj&#228;rrmetastaser i andra delar av kroppen.
&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aeggstockscancer-81020?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aeggstockscancer-81020?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>F&#246;rekomst av &#228;ggstockscancer i v&#228;rlden</title>
  <pubDate>Mon, 06 Jun 2011 16:00:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/sjukdomsfoerekomst-i-vaerlden-81018" title="F&#246;rekomst av &#228;ggstockscancer i v&#228;rlden"&gt;&lt;img alt="F&#246;rekomst av &#228;ggstockscancer i v&#228;rlden" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/annotated_map_sv.jpg" title="F&#246;rekomst av &#228;ggstockscancer i v&#228;rlden" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/sjukdomsfoerekomst-i-vaerlden-81018?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/sjukdomsfoerekomst-i-vaerlden-81018?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Tum&#246;rincindens vs d&#246;dlighet i Sverige f&#246;r cancersjukdomar som drabbar kvinnor</title>
  <pubDate>Mon, 06 Jun 2011 15:57:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/tumoerincindens-vs-doedlighet-i-sverige-81017" title="Tum&#246;rincindens vs d&#246;dlighet i Sverige f&#246;r cancersjukdomar som drabbar kvinnor"&gt;&lt;img alt="Tum&#246;rincindens vs d&#246;dlighet i Sverige f&#246;r cancersjukdomar som drabbar kvinnor" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/3b-mortality-aw-sv.jpg" title="Tum&#246;rincindens vs d&#246;dlighet i Sverige f&#246;r cancersjukdomar som drabbar kvinnor" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/tumoerincindens-vs-doedlighet-i-sverige-81017?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/tumoerincindens-vs-doedlighet-i-sverige-81017?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Patienter med EGFR-muterad tum&#246;r i lungan f&#229;r god effekt med Tarceva</title>
  <pubDate>Mon, 06 Jun 2011 15:39:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/patienter-med-egfr-muterad-tumoer-faar-god-effekt-med-tarceva-81013" title="Patienter med EGFR-muterad tum&#246;r i lungan f&#229;r god effekt med Tarceva"&gt;&lt;img alt="Patienter med EGFR-muterad tum&#246;r i lungan f&#229;r god effekt med Tarceva" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/spoons-image1c-aw-modif.jpg" title="Patienter med EGFR-muterad tum&#246;r i lungan f&#229;r god effekt med Tarceva" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/patienter-med-egfr-muterad-tumoer-faar-god-effekt-med-tarceva-81013?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/patienter-med-egfr-muterad-tumoer-faar-god-effekt-med-tarceva-81013?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>EGFR-receptorn skickar signaler till cellen om att dela sig</title>
  <pubDate>Mon, 06 Jun 2011 15:34:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/egfr-receptorn-skickar-signaler-till-cellen-om-att-dela-sig-81012" title="EGFR-receptorn skickar signaler till cellen om att dela sig"&gt;&lt;img alt="EGFR-receptorn skickar signaler till cellen om att dela sig" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/spoons-image1b-aw-modif.jpg" title="EGFR-receptorn skickar signaler till cellen om att dela sig" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/egfr-receptorn-skickar-signaler-till-cellen-om-att-dela-sig-81012?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/egfr-receptorn-skickar-signaler-till-cellen-om-att-dela-sig-81012?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>EGFR kan ha betydelse vid lungcancer</title>
  <pubDate>Mon, 06 Jun 2011 15:31:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/egfr-kan-ha-betydelse-vid-lungcancer-81011" title="EGFR kan ha betydelse vid lungcancer"&gt;&lt;img alt="EGFR kan ha betydelse vid lungcancer" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/spoons-image1a-aw.jpg" title="EGFR kan ha betydelse vid lungcancer" /&gt;&lt;/a&gt;
    &lt;p&gt;&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/egfr-kan-ha-betydelse-vid-lungcancer-81011?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/egfr-kan-ha-betydelse-vid-lungcancer-81011?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>&#197;rets Br&#246;stv&#228;nner 2010</title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/aarets-broestvaenner-2010-74321" title="&#197;rets Br&#246;stv&#228;nner 2010"&gt;&lt;img alt="&#197;rets Br&#246;stv&#228;nner 2010" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_6231.jpg" title="&#197;rets Br&#246;stv&#228;nner 2010" /&gt;&lt;/a&gt;
    &lt;p&gt;Fr&#229;n v&#228;nster: Lena Sandell och Ann-Charlotte Pellettieri. 

F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aarets-broestvaenner-2010-74321?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/aarets-broestvaenner-2010-74321?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Halsband &#8211; design Suzanne F&#228;rnert</title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/halsband-design-suzanne-faernert-74318" title="Halsband &#8211; design Suzanne F&#228;rnert"&gt;&lt;img alt="Halsband &#8211; design Suzanne F&#228;rnert" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_5824.jpg" title="Halsband &#8211; design Suzanne F&#228;rnert" /&gt;&lt;/a&gt;
    &lt;p&gt;Pristagarna mottog, f&#246;rutom diplomet, &#228;ven ett halssmycke designat av Suzanne F&#228;rnert.
F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/halsband-design-suzanne-faernert-74318?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/halsband-design-suzanne-faernert-74318?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Ann Charlotte och Lena &#8211; &#197;rets Br&#246;stv&#228;nner 2010 </title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/ann-charlotte-och-lena-aarets-broestvaenner-2010-74313" title="Ann Charlotte och Lena &#8211; &#197;rets Br&#246;stv&#228;nner 2010 "&gt;&lt;img alt="Ann Charlotte och Lena &#8211; &#197;rets Br&#246;stv&#228;nner 2010 " src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_6013.jpg" title="Ann Charlotte och Lena &#8211; &#197;rets Br&#246;stv&#228;nner 2010 " /&gt;&lt;/a&gt;
    &lt;p&gt;F&#246;r mer information kring projektet BreastFriends g&#229; in p&#229;: www.breastfriends.se

F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen


&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/ann-charlotte-och-lena-aarets-broestvaenner-2010-74313?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/ann-charlotte-och-lena-aarets-broestvaenner-2010-74313?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Ann Charlotte Pellettieri &#8211; &#197;rets Br&#246;stv&#228;n i kategorin V&#229;rdpersonal </title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/ann-charlotte-pellettieri-aarets-broestvaen-i-kategorin-vaardpersonal-74311" title="Ann Charlotte Pellettieri &#8211; &#197;rets Br&#246;stv&#228;n i kategorin V&#229;rdpersonal "&gt;&lt;img alt="Ann Charlotte Pellettieri &#8211; &#197;rets Br&#246;stv&#228;n i kategorin V&#229;rdpersonal " src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_6164.jpg" title="Ann Charlotte Pellettieri &#8211; &#197;rets Br&#246;stv&#228;n i kategorin V&#229;rdpersonal " /&gt;&lt;/a&gt;
    &lt;p&gt;Genom att kombinera sina kunskaper inom kognitiv beteendeterapi, samtalsterapi och yoga hj&#228;lper hon sin patient att i sjukdomen l&#228;ra k&#228;nna sin kropp, finna livsgl&#228;dje och orka leva vidare.

F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/ann-charlotte-pellettieri-aarets-broestvaen-i-kategorin-vaardpersonal-74311?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/ann-charlotte-pellettieri-aarets-broestvaen-i-kategorin-vaardpersonal-74311?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Lena Sandell &#8211; vinnare av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010 i kategorin privatperson. </title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/lena-sandell-vinnare-av-utmaerkelsen-aarets-broestvaen-2010-i-kategorin-privatperson-74307" title="Lena Sandell &#8211; vinnare av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010 i kategorin privatperson. "&gt;&lt;img alt="Lena Sandell &#8211; vinnare av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010 i kategorin privatperson. " src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_6089_1.jpg" title="Lena Sandell &#8211; vinnare av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010 i kategorin privatperson. " /&gt;&lt;/a&gt;
    &lt;p&gt; Lena Sandell har visat att medm&#228;nsklighet och st&#246;d str&#228;cker sig f&#246;rbi v&#228;nskapsrelationer. 

F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/lena-sandell-vinnare-av-utmaerkelsen-aarets-broestvaen-2010-i-kategorin-privatperson-74307?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/lena-sandell-vinnare-av-utmaerkelsen-aarets-broestvaen-2010-i-kategorin-privatperson-74307?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Vinnarna av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010</title>
  <pubDate>Wed, 13 Apr 2011 14:15:00 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/vinnarna-av-utmaerkelsen-aarets-broestvaen-2010-74304" title="Vinnarna av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010"&gt;&lt;img alt="Vinnarna av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/_mg_6283.jpg" title="Vinnarna av utm&#228;rkelsen &#197;rets Br&#246;stv&#228;n 2010" /&gt;&lt;/a&gt;
    &lt;p&gt;Fr&#229;n v&#228;nster: Ann-Charlotte Pellettieri och Lena Sandell.

F&#246;r mer info kring &#197;rets Br&#246;stv&#228;n:
http://www.mynewsdesk.com/se/pressroom/roche_ab/tag/aarets-broestvaen

&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/vinnarna-av-utmaerkelsen-aarets-broestvaen-2010-74304?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/vinnarna-av-utmaerkelsen-aarets-broestvaen-2010-74304?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Br&#246;stcancer stadium IV - spridd br&#246;stcancer</title>
  <pubDate>Sat, 30 May 2009 09:15:15 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/broestcancer-stadium-iv-spridd-broestcancer-20009" title="Br&#246;stcancer stadium IV - spridd br&#246;stcancer"&gt;&lt;img alt="Br&#246;stcancer stadium IV - spridd br&#246;stcancer" src="http://resources0.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/brostcancer_stadium_iv_-_spridd_brostcancer.jpg" title="Br&#246;stcancer stadium IV - spridd br&#246;stcancer" /&gt;&lt;/a&gt;
    &lt;p&gt;Cancern har spridit sig (metastaserat) till andra organ i kroppen, som lunga, lever eller skelett.&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/broestcancer-stadium-iv-spridd-broestcancer-20009?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/broestcancer-stadium-iv-spridd-broestcancer-20009?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
<item>
  <title>Br&#246;stcancer stadium III - spridd br&#246;stcancer</title>
  <pubDate>Sat, 30 May 2009 09:14:28 +0200</pubDate>
  <description>
    &lt;a href="/se/pressroom/roche_ab/image/view/broestcancer-stadium-iii-spridd-broestcancer-20008" title="Br&#246;stcancer stadium III - spridd br&#246;stcancer"&gt;&lt;img alt="Br&#246;stcancer stadium III - spridd br&#246;stcancer" src="http://resources1.mynewsdesk.com/files/a61a1509368a7660d973bb1327ede700/resources/ResourceImage/large_high/brostcancer_stadium_iii_-_spridd_brostcancer.jpg" title="Br&#246;stcancer stadium III - spridd br&#246;stcancer" /&gt;&lt;/a&gt;
    &lt;p&gt;Tum&#246;ren &#228;r mycket stor (mer &#228;n 5 centimeter) eller v&#228;xer fast i omgivande v&#228;vnad. Kallas &#228;ven lokalt avancerad br&#246;stcancer.&lt;/p&gt;
  </description>
  <guid>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/broestcancer-stadium-iii-spridd-broestcancer-20008?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</guid>
  <link>http://www.mynewsdesk.com/se/pressroom/roche_ab/image/view/broestcancer-stadium-iii-spridd-broestcancer-20008?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=image</link>
  <dc:creator>Roche AB</dc:creator>
</item>
  </channel>
</rss>

